Feasibility of using machine learning on insurance claims to identify correlates of lower extremity amputation in insured adults with type 2 diabetes who initiate treatment with sodium-glucose co-transporter 2 (SGLT-2) inhibitors.

Yuan Luo, Andrew J. Cooper, Raymond Kang, Ronald Ackermann

Browse the full AMIA paper archive.